ATE7655T1 - Arzneizubereitung mit verzoegerter wirkstoffabgabe und verfahren zu deren herstellung. - Google Patents

Arzneizubereitung mit verzoegerter wirkstoffabgabe und verfahren zu deren herstellung.

Info

Publication number
ATE7655T1
ATE7655T1 AT81302895T AT81302895T ATE7655T1 AT E7655 T1 ATE7655 T1 AT E7655T1 AT 81302895 T AT81302895 T AT 81302895T AT 81302895 T AT81302895 T AT 81302895T AT E7655 T1 ATE7655 T1 AT E7655T1
Authority
AT
Austria
Prior art keywords
component
melting
finely divided
manufacture
melting point
Prior art date
Application number
AT81302895T
Other languages
German (de)
English (en)
Inventor
Helmut Augart
Original Assignee
Goedecke Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6105792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE7655(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Goedecke Aktiengesellschaft filed Critical Goedecke Aktiengesellschaft
Application granted granted Critical
Publication of ATE7655T1 publication Critical patent/ATE7655T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT81302895T 1980-06-28 1981-06-26 Arzneizubereitung mit verzoegerter wirkstoffabgabe und verfahren zu deren herstellung. ATE7655T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3024416A DE3024416C2 (de) 1980-06-28 1980-06-28 Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
EP81302895A EP0043254B1 (en) 1980-06-28 1981-06-26 Retarded release pharmaceutical composition and process for producing the same

Publications (1)

Publication Number Publication Date
ATE7655T1 true ATE7655T1 (de) 1984-06-15

Family

ID=6105792

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81302895T ATE7655T1 (de) 1980-06-28 1981-06-26 Arzneizubereitung mit verzoegerter wirkstoffabgabe und verfahren zu deren herstellung.

Country Status (15)

Country Link
US (1) US4483847A (enExample)
EP (1) EP0043254B1 (enExample)
JP (1) JPS5738711A (enExample)
AT (1) ATE7655T1 (enExample)
AU (1) AU545279B2 (enExample)
CA (1) CA1165691A (enExample)
DD (1) DD159966A5 (enExample)
DE (2) DE3024416C2 (enExample)
DK (1) DK155711C (enExample)
ES (1) ES8301625A1 (enExample)
FI (1) FI76928C (enExample)
HU (1) HU184862B (enExample)
IE (1) IE51353B1 (enExample)
SU (1) SU1360575A3 (enExample)
ZA (1) ZA814094B (enExample)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5959632A (ja) * 1982-09-28 1984-04-05 Teikoku Chem Ind Corp Ltd 徐放性組成物
US4713245A (en) * 1984-06-04 1987-12-15 Mitsui Toatsu Chemicals, Incorporated Granule containing physiologically-active substance, method for preparing same and use thereof
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
US4755387A (en) * 1985-03-21 1988-07-05 The Procter & Gamble Company Therapeutic particles
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
US4820523A (en) * 1986-04-15 1989-04-11 Warner-Lambert Company Pharmaceutical composition
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
US4822619A (en) * 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
JP2668880B2 (ja) * 1987-06-23 1997-10-27 日本油脂株式会社 被覆アミノ酸類の製造方法
DE3737741A1 (de) * 1987-11-06 1989-05-18 Goedecke Ag Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
US5134016A (en) * 1990-10-31 1992-07-28 E. I. Du Pont De Nemours And Company Fiber reinforced porous sheets
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
DE59302200D1 (de) * 1992-05-22 1996-05-15 Goedecke Ag Verfahren zur herstellung retardierter arzneimittelzubereitungen
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
MX9707585A (es) * 1995-04-03 1997-12-31 Abbott Lab Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
DE19522899C1 (de) * 1995-06-23 1996-12-19 Hexal Pharmaforschung Gmbh Verfahren zum kontinuierlichen Ersintern eines Granulats
KR100508910B1 (ko) 1995-10-17 2006-04-20 알티피 파마 코포레이션 불용성약물방출
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
DE19705538C1 (de) * 1997-02-14 1998-08-27 Goedecke Ag Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
DE69908304T2 (de) * 1998-02-11 2004-02-19 Rtp Pharma Corp. Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
AU764001B2 (en) 1998-05-29 2003-08-07 Skyepharma Canada Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
ATE252889T1 (de) 1998-08-19 2003-11-15 Skyepharma Canada Inc Injizierbare wässerige propofoldispersionen
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
PL201578B1 (pl) 1998-11-20 2009-04-30 Skyepharma Canada Inc Stała terapeutyczna postać dawkowania nierozpuszczalnego lub słabo rozpuszczalnego w wodzie związku
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
KR20020011985A (ko) * 1999-05-07 2002-02-09 파르마솔 게엠베하 액상 및 고체상 지질 혼합물에 기초한 지질입자들 및 그의제조방법
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2295043A1 (en) 1999-10-29 2011-03-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
NZ522239A (en) 2000-04-20 2004-03-26 Skyepharma Canada Inc Improved water-insoluble drug particle process
CA2420597C (en) 2000-08-31 2011-05-17 Rtp Pharma Inc. Milled particles
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
EP2932964A1 (en) 2000-10-30 2015-10-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
ATE373471T1 (de) * 2000-12-27 2007-10-15 Ares Trading Sa Lipidmikropartikel mittels kryogenischer mikronisierung
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10300325A1 (de) 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
BRPI0407181A (pt) 2003-02-03 2006-02-07 Novartis Ag Formulação farmacêutica
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
RU2267318C1 (ru) * 2004-05-25 2006-01-10 Закрытое акционерное общество "ФАРМАПЭК" Пролонгированный антиангинальный препарат изосорбида динитрата и способ его получения
LT1765292T (lt) 2004-06-12 2018-01-10 Collegium Pharmaceutical, Inc. Nuo piktnaudžiavimo apsaugotos vaistų formos
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
EP2049087A2 (en) * 2006-07-21 2009-04-22 LAB International SRL Hydrophilic abuse deterrent delivery system
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
ES2441550T3 (es) * 2007-12-21 2014-02-05 Ludwig-Maximilians-Universität Dispositivos extruidos con forma de varilla para la Iiberación controlada de sustancias biológicas a humanos y animales
RU2493830C2 (ru) 2008-01-25 2013-09-27 Грюненталь Гмбх Лекарственная форма
LT2273983T (lt) 2008-05-09 2016-10-25 Grünenthal GmbH Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija
JP5667183B2 (ja) 2009-07-22 2015-02-12 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 加熱溶融押出成型した制御放出性投与剤型
RU2567723C2 (ru) 2009-07-22 2015-11-10 Грюненталь Гмбх Стабильная при окислении, прочная на излом лекарственная форма
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP2531176B1 (en) 2010-02-03 2016-09-07 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of an extruder
CA2808541C (en) 2010-09-02 2019-01-08 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
EP2611426B1 (en) 2010-09-02 2014-06-25 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
JP2014524925A (ja) 2011-07-29 2014-09-25 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時薬剤放出を提供するタンパーレジスタント錠剤
US20130028972A1 (en) 2011-07-29 2013-01-31 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
CA2868142A1 (en) 2012-04-18 2013-10-24 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2913209A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １個または複数の粒子を含有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
BR112016000194A8 (pt) 2013-07-12 2019-12-31 Gruenenthal Gmbh forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
BR112016010482B1 (pt) 2013-11-26 2022-11-16 Grünenthal GmbH Preparação de uma composição farmacêutica em pó por meio de criomoagem
JP2017518980A (ja) 2014-05-12 2017-07-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールを含む、改変防止即時放出カプセル製剤
JP2017516789A (ja) 2014-05-26 2017-06-22 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エタノール過量放出に対して防護されている多粒子
WO2016023924A1 (en) * 2014-08-11 2016-02-18 Perora Gmbh Method of inducing satiety
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
US10231903B2 (en) 2016-11-10 2019-03-19 Medisca Pharmaceutique Inc. Pharmaceutical compounding methods and systems
EP3492070A1 (en) * 2017-11-30 2019-06-05 BIT Pharma GmbH Process and device for preparing a solid dispersion

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
GB906422A (en) * 1958-05-02 1962-09-19 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical preparations
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US3279998A (en) * 1962-06-22 1966-10-18 Smith Kline French Lab Method of preparing sustained release tablets
GB1021924A (en) * 1962-06-22 1966-03-09 Smith Kline French Lab Improvements in or relating to method of preparing sustained release tablets
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
US3487138A (en) * 1966-11-23 1969-12-30 Merck & Co Inc Process for preparing a delayed release medicinal tablet
DE1617418C3 (de) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe
NL6808619A (enExample) * 1968-06-19 1969-12-23
GB1312918A (en) * 1969-07-08 1973-04-11 Beecham Group Ltd Veterinary treatment
DK121813B (da) * 1969-12-10 1971-12-06 C Mangen Fremgangsmåde til fremstilling af tabletlignende doseringsenheder.
DE2426811A1 (de) * 1974-06-04 1976-01-08 Klinge Co Chem Pharm Fab Verfahren zur herstellung von retard-tabletten

Also Published As

Publication number Publication date
FI76928B (fi) 1988-09-30
DE3024416A1 (de) 1982-01-21
HU184862B (en) 1984-10-29
CA1165691A (en) 1984-04-17
DD159966A5 (de) 1983-04-20
AU545279B2 (en) 1985-07-11
DK278381A (da) 1981-12-29
AU7206981A (en) 1982-01-07
JPS5738711A (en) 1982-03-03
ES503414A0 (es) 1983-01-01
ES8301625A1 (es) 1983-01-01
US4483847A (en) 1984-11-20
EP0043254B1 (en) 1984-05-30
DE3163868D1 (en) 1984-07-05
EP0043254A1 (en) 1982-01-06
IE811438L (en) 1981-12-28
FI76928C (fi) 1989-01-10
JPS6140204B2 (enExample) 1986-09-08
ZA814094B (en) 1982-07-28
SU1360575A3 (ru) 1987-12-15
IE51353B1 (en) 1986-12-10
FI811951L (fi) 1981-12-29
DE3024416C2 (de) 1982-04-15
DK155711B (da) 1989-05-08
DK155711C (da) 1989-10-23

Similar Documents

Publication Publication Date Title
ATE7655T1 (de) Arzneizubereitung mit verzoegerter wirkstoffabgabe und verfahren zu deren herstellung.
ATE212224T1 (de) Verfahren zur herstellung einer arzneizusammensetzung mit verzögerter wirkstoffabgabe
HUT34891A (en) Process for producing compositions with controlled dissolution of active ingredients
ATE145131T1 (de) Ueberzogene zusammensetzung sowie verfahren zu ihrer herstellung
ATA379182A (de) Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
PT67455A (en) Process for preparing of 7epsilon-(alkoxycarbonyl)-6epsilon-alkyl/halo-17-hydroxy-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid gamma-lactones and corresponding 21-carboxylic acids,their salts and esters
ATA268783A (de) Verfahren zur herstellung von neuen pyridinen und deren aklansaeureestern, methylaethern sowie pharmazeutisch annehmbaren saeureadditionssalzen
EG11891A (en) Process for preparing of pyrimidinylthionophosphonic acid esters,process for their preparation and their use as insecticides,acaricides and nematocides
AT361906B (de) Verfahren zur herstellung von neuen 2,4,6- trijodbenzonitrilen sowie deren estern, saeure- amiden und salzen
AT345826B (de) Verfahren zur herstellung von neuen behensaeureestern, deren isomeren und saeure- additionssalzen
AT347921B (de) Verfahren zur herstellung von neuen 3- (4'-p- halogenphenoxyphenyl)-2-buten-1-olen und -butan-1-olen sowie deren alkansaeureestern
AT346827B (de) Verfahren zur herstellung von neuen 3- aminomethyl-2-phenyl-bicyclo (2,2,2) octanen und -octenen sowie deren saeureadditionssalzen
ATE72110T1 (de) Pharmazeutische zubereitung mit kontrollierter und verzoegerter wirkstofffreigabe und verfahren zu deren herstellung.
ZA751971B (en) Pyrimidin(2)yl - thionophosphoric acid esters, process for their preparation and their use as insecticides, acaricides and nematocides
EG12138A (en) Process for preparing of o-pyrazolopyrimidin-ethionothiolphosphoric acid esters and their use as insecticides,acaricides and nematicides
AT359066B (de) Verfahren zur herstellung von neuen 6,11- dihydro-11-oxodibenz(b,e)oxepin-alkansaeuren und deren estern sowie deren salzen
AT375937B (de) Verfahren zur herstellung von 9-hydrazono-6,7,8, 9-tetrahaydro-4h-pyrido (1,2-a) - pyrimidin-4-on- derivaten sowie von deren physiologisch vertraeglichen salzen, hydraten und isomeren
LU79430A1 (de) Verfahren zur herstellung von 2-hydroxy-2-(5-isoxazolylmethyl)-6,7-benzomorphanen,von deren saeureadditionssalzen und diese enthaltenden arzneimitteln
ATA596780A (de) Verfahren zur herstellung von neuen indolizinderivaten und von deren pharmazeutisch zulaessigen saeureadditionssalzen
ATA77579A (de) Verfahren zur herstellung neuer pyrano(4,3-e)-as- triazine und ihrer sauren additionssalze
AT353768B (de) Verfahren zur herstellung neuer amino- saeurederivate sowie deren salzen und optisch aktiven antipoden
CS180802B1 (en) Method for producing melt of polycondensed ammonium phosphates and device for making the said method
AT349470B (de) Verfahren zur herstellung von neuen 4,4- diphenylcyclohexylpiperidinderivaten sowie deren pharmazeutisch anwendbaren saeureadditionssalzen
DE3060933D1 (en) Steroidal phosphonothioate compounds, process for preparing them, compositions containing said compounds, process for preparing said compositions, method of producing an antiserum and method of radioimmunoassay
CS189781B2 (en) Method of producing esters of 3-oxim-17 alpha-ethinyl-19-nortestosterone in the form of d-isomere

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time